Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Huons Wins Three State Drug Development Grants With Biotech Partners
14+ hour, 55+ min ago (339+ words) Joint Projects With SurgeneX, PinotBio and PulseInMyEars Programs Span mRNA Eye Drops, ADC and Peptide Cancer Drug Huons is moving to develop drug candidates across three different modalities — an mRNA eye drop, an antibody-drug conjugate (ADC) and a peptide cancer…...
AI-Driven Pharmaceutical R&D Infrastructure Competition: Key Trends, Strategies & Industry Impact
15+ hour, 2+ min ago (980+ words) When AI pushes drug design to the "minute-level", laboratories capable of validating such outputs are equally scarce. Swiss startup Adaptyv Bio completed wet experimental validation of 1320 protein sequences for Anthropic's Claude. Its revenue has increased nearly 10 times in the past…...
Servier Partnering Day: Connecting Pharma, Biotech, and Academia for New Opportunities - OncoDaily
19+ hour, 20+ min ago (107+ words) Servier shared on LinkedIn: “We are excited to announce that the next edition of the Servier Partnering Day will take place in our Paris-Saclay R/D Institute on November 23rd! This unique event is designed to bring together pharma and biotech…...
AI researchers explore fine-tuning foundation models for biology and drug discovery
1+ day, 10+ hour ago (62+ words) indica News Adapting foundation models to the complexities of human biology is emerging as a new frontier in artificial intelligence-driven health care, researchers and industry executives said at a recent panel discussion in San Carlos, California... To continue reading, please…...
A billion-dollar drug was found in Easter Island soil – what scientists and companies owe the Indigenous people they studied
21+ hour, 58+ min ago (295+ words) Cancer. Diabetes. Aging itself. Rapamycin’s potential to treat an array of diseases has been a source of scientific fascination. But many aren’t aware of its origins – and its complicated legacy....
The week in pharma: action, reaction and insight – week to September 11, 2026
1+ day, 3+ hour ago (323+ words) Last week’s regulatory news saw the US Food and Drug Administration (FDA) grant accelerated approval for AstraZeneca’s Etcamah combination for the treatment of breast cancer. On the research front, Novartis suffered another setback, this time with its Phase III trial…...
Akeso details survival win for its PD-1xVEGF drug versus Keytruda
1+ day, 14+ hour ago (76+ words) Endpoints News Akeso details survival win for its PD-1xVEGF drug versus Keytruda Akeso and Summit Therapeutics claimed a key win over Keytruda at the start of September,…...
Scientists Flip the Drug Discovery Pipeline to Put Human Biology First in
1+ day, 9+ hour ago (704+ words) Cardiovascular medicine is quietly undergoing a structural rethink, and the change begins with the order of operations....
AI That Learns the Rules: Symbolic Neural Generators Design New Drug
1+ day, 10+ hour ago (90+ words) Artificial intelligence has become an increasingly powerful tool in the search for new medicines, but a persistent problem has haunted the field: neural networks that invent molecules are remarkably creative yet notoriously unreliable. They can propose chemical structures that look…...
New Biohacker Company Promises Unicorns. What’s the Catch?
1+ day, 20+ hour ago (432+ words) Unicorns, dragons, pixies, and the like are the stuff of kids' stories, or at least they should be. But now a new Texas startup, a bioengineering firm, The Embryo Corporation, is looking at the possibility of producing these creatures for…...